Zynex Medical’s cover photo
Zynex Medical

Zynex Medical

Medical Equipment Manufacturing

Englewood, Colorado 25,764 followers

World Premier Pain Management Device Manufacturer & Distributor

About us

Zynex, Inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. Zynex Medical is a provider of electrotherapy products for home use. Zynex Monitoring Solutions develops products for cardiac monitoring for use in hospitals. Zynex NeuroDiagnostics develops devices for EMG and EEG diagnostic applications within neurology disciplines. Zynex Medical's product line is fully developed, FDA/CE cleared, commercially sold, and has been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex Monitoring Solutions and Zynex NeuroDiagnostics are currently both in the development stages without any significant revenues.

Industry
Medical Equipment Manufacturing
Company size
501-1,000 employees
Headquarters
Englewood, Colorado
Type
Public Company
Founded
1996
Specialties
Develop Stroke Rehabilitation and Pain Management Devices, Markets TENS, Interferential (IFC), & NMES, Developing Blood Monitoring Solution, and Developing Neuro Diagnostic Application Device

Locations

Employees at Zynex Medical

Updates

  • The opioid crisis continues to impact our nation, especially veterans facing the dangers of opioid overprescription. Our Veterans deserve safer, more effective pain management options. That’s why #Zynex is committed to providing alternative solutions to help relieve suffering from all types of pain -- Because those who’ve sacrificed for us deserve better care. #ZynexMedical #Veterans #PainManagement #OpioidCrisis

    View organization page for The Sandgaard Foundation

    870 followers

    Veterans Betrayed by the #Opioid Epidemic. This ongoing tragedy isn’t a natural disaster but a man-made one. The opioid crisis continues to devastate communities, leaving families and veterans in unimaginable pain. This man-made tragedy, fueled by corporate greed, highlights the need for accountability from pharmaceutical companies and consulting firms like McKinsey, which prioritized profit over lives. Veterans, who served our nation with honor, were victimized by aggressive opioid marketing and overprescription strategies. We must demand justice and transparency to prevent future public health disasters. The Alternatives to PAIN Act offers hope, promoting safer, non-opioid pain management for veterans. Let’s honor those affected by pushing for change and ensuring this never happens again. #OpioidCrisis #Accountability #VeteransDeserveBetter #HarmReduction #Recovery #EndOverdose #EndStigma #SaveLives Read the entire article here to learn more: https://lnkd.in/gpwjRtSS

    • No alternative text description for this image
  • Struggling with patient compliance after sessions? Our cervical traction devices deliver the same high-quality traction your patients need, while allowing them to treat in the comfort of their own home. Designed for reliable performance and effective pain relief, these devices empower your patients to continue their recovery on their own time. Connect with us today to learn more about this at-home treatment option! #Zynex #ZynexMedical #PatientCare #CervicalTraction #PhysicalTherapy

  • View organization page for Zynex Medical

    25,764 followers

    Don’t risk having patients deal with the dangerous side effects of opioids, especially with new evidence linking their use to changes in brain function. Consider safer and drug-free alternatives for patient pain management with #Zynex. The #NexWave is significantly stronger than TENS and offers 3 pre-programmed modalities to help patients manage their pain symptoms. Learn more about the NexWave: https://lnkd.in/e7naz4a #ZynexMedical #OpioidCrisis #IFC #PainRelief #Drugfree #YaleUniversity #Research

    🧠🔄 Opioid use disorder might lead to ‘sticky’ brains. Yale University researchers found that individuals with opioid use disorder were less able to flexibly engage different patterns of brain activity. New research finds that individuals with opioid use disorder struggle to switch between brain states—especially after seeing opioid-related images. 🏥🩺 This brain "stickiness" may explain difficulties in cognitive control and resisting cravings. Future treatments, like non-invasive brain stimulation (TMS), could help improve brain flexibility. 💡 Understanding the brain’s response to opioids is key to better treatments and recovery! Click the following link to learn more: https://lnkd.in/gQn2gQtE #OpioidCrisis #AddictionScience #Neuroscience

    • No alternative text description for this image
  • The only way out is through! Let’s continue working together towards fighting the opioid crisis. To aid in our mission, #Zynex offers a variety of pain management options that can help patients find relief, like those suffering from chronic pain, post-operative pain, and more. Learn more about our products and connect with one of our representatives today at Zynex.com. #ZynexMedical #PainManagement #PainRelief #OpioidCrisis 

    📉 Drug Deaths Decline, But Challenges Remain 💔💊 Overdose deaths are down in Hamilton County & much of the U.S., offering hope in the opioid crisis. 🚑 Increased access to Narcan, treatment programs & community outreach are saving lives. Sarah Coyne, an outreach worker, has revived users & helped families navigate addiction. But experts warn: the drop in deaths isn’t all success—many users have built tolerance, and fewer people are left to succumb. Hope is rising, but the fight isn’t over. #OpioidCrisis #HarmReduction #RecoveryMatters Read the entire article here to learn more: https://lnkd.in/gTb7gRxV

    • No alternative text description for this image
  • “Pain relief with high-frequency, high-intensity transcutaneous electrical nerve stimulation (TENS) is comparable with intravenous opioids in managing postsurgical pain…” The study also found no difference in the length of stay in the post-anesthesia care unit (PACU) between opioid and electric analgesia in patients who undergo laparoscopic surgery. Fortunately, the #NexWave offers 3 pre-programmed modalities, including TENS and IFC, which can help patients manage pain symptoms and reduce opioid medication usage. Learn more about the NexWave for a better and safer way to manage pain: https://lnkd.in/e7naz4a #Zynex #OpioidCrisis #TENS #IFC #Postop #Pain #PainRelief

    Medscape: "TENS Matches Opioids for Pain Relief After Surgery" TOPLINE: Pain relief with high-frequency, high-intensity transcutaneous electrical nerve stimulation (TENS) is comparable with intravenous opioids in managing postsurgical pain in patients who undergo laparoscopic surgery for gallbladder removal. IN PRACTICE: "High-frequency, high-intensity TENS may be considered an opioid-sparing option for postoperative pain relief and could be envisioned as a first line of treatment for patients reporting postoperative pain intensity at arrival in the PACU rated as NRS ≤ 5, and for patient populations that are vulnerable to the adverse effects of opioids," the authors wrote. METHODOLOGY: Researchers assessed 163 patients who underwent laparoscopic cholecystectomy at two Swedish centers between 2019 and 2023. Patients who experienced postoperative pain with a numerical rating scale (NRS) score ≥ 3 in the post-anesthesia care unit (PACU) were randomly assigned to receive either TENS or an intravenous opioid. The primary outcome was the duration of stay in the PACU. TAKEAWAY: The researchers found no difference in the length of stay in the PACU between electric analgesia and opioid (mean, 138 vs 142 minutes; P = .74). Both groups reported similar pain intensity (P = .58), nausea (P = .34), and sedation (P = 1.00) at discharge from the PACU. Patients in both groups reported high satisfaction with pain treatment and overall care, with no differences in the mean hospital stay (587 vs 697 minutes; P = .67). The overall consumption of opioids was lower in the TENS group (4.53 vs 11.10 morphine equivalents; P < .001); however, 46% of patients in this group needed additional opioid treatment. SOURCE: The study was led by Cecilia Ögren, of the Department of Anesthesiology and Intensive Care/Pain Centre at Region Västra Götaland at the Sahlgrenska University Hospital in Gothenburg, Sweden, and published online on June 29 in the European Journal of Pain. BENEFITS of TENS  Can be used as an alternative to opioids Can help patients feel more in control of their pain Can help patients move around more and recover faster Can reduce the need for pain medication DISCLOSURES: The study was supported by Swedish Government, the County Councils, and The Healthcare Board, Region Västra Götaland. The authors did not declare any conflicts of interest. Click here to read more from Medscape: https://lnkd.in/g6T28uwJ

    • No alternative text description for this image

Similar pages

Browse jobs

Stock

ZYXI

NASDAQ

20 minutes delay

$7.42

-0.13 (-1.722%)

Open
7.47
Low
7.3
High
7.58

Data from Refinitiv

See more info on Bing